Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer

International Journal of Biological Markers

Volumn 18, Issue 1, 2003, Pages 1-6

  Gilles, S I ^a   Romain, Sylvie ^a   Casellas, P ^b   Ouafik, L 'H ^a   Fina, F ^a   Combes, T ^b   Vuaroquaux, V ^a   Seitz, J F ^c   Bonnier, P ^d   Galiegue S ^b   Carayon, P ^b   Martin, P M ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b SANOFI   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Breast cancer; Colorectal cancer; Mutation; Polymorphism; Thymidine kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; PROTEIN TYROSINE KINASE; THYMIDINE KINASE; THYMIDINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING SITE; BREAST CANCER; CELL PROLIFERATION; CLINICAL ARTICLE; CODON; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CYTOSOL; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXON; FEMALE; GENE LOCATION; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SOLID TUMOR;

EID: 0142217969     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.2452     Document Type: Article

References (22)

1. Arner ES, Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther 1995; 67: 155-86.
2. Xu WM, Gorman PA, Rider SH, et al. Construction of a genetic map of human chromosome 17 by use of chromosome-mediated gene transfer. Proc Natl Acad Sci USA 1988; 85: 8563-7.
3. Flemington E, Bradshaw Jr., HD Traina-Dorge V, Slagel V, Deininger PL, Sequence, structure and promoter characterization of the human thymidine kinase gene. Gene 1987; 52: 267-77.
4. Madec A, Javre JL, Haras D, Samperez S, Jouan P. Some characteristics of fetal and adult isoenzymes of thymidine kinase in human breast cancers. Bull Cancer 1988; 75: 187-94.
5. Sakamoto S, Iwama T, Tsukada K, Utsunomiya J, Kawasaki T, Okamoto R. Increased activity of thymidine kinase isozyme in human colon tumor. Carcinogenesis 1984; 5: 183-5.
6. Spyratos F, Martin PM, Hacene K, et al. Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 1992; 84: 1266-72.
7. Romain S, Christensen IJ, Chinot O, et al. Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. Int J Cancer 1995; 61: 7-12.
8. Romain S, Spyratos F, Descotes F, et al. Prognostic assessment of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: A retrospective multicenter study. Int J Cancer 2000; 87: 860-8.
9. Broët P, Romain S, Daver A, et al. Thymidine kinase as a proliferative marker: Clinical relevance in 1692 primary breast cancer patients. J Clin Oncol 2001; 19: 2778-87.
10. Romain S, Bendahl PO, Guirou O, Malmström P, Martin PM, Fernö M. DNA synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients. Int J Cancer 2001; 95: 56-61.
11. Tanigawa N, Masuda Y, Muraoka R, Tanaka T. Prognostic significance of in vitro thymidine uptake in patients with colorectal carcinoma. J Surg Oncol 1994; 55: 209-14.
12. Luccioni C, Muleris M, Sabatier L, Dutrillaux B. Chromosomal and enzymatic patterns provide evidence for two types of human colon cancers with abnormal nucleotide metabolism. Mutat Res 1988; 200: 55-62.
13. Zou L, Zhang PG, Zou S, Li Y, He Q. The half-life of thymidine kinase 1 in serum measured by ECL dot blot: A potential marker for monitoring the response to surgery of patients with gastric cancer. Int J Biol Markers 2002; 17: 135-40.
14. He Q, Zou L, Zhang PA, Lui JX, Skog S, Fornander T. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody. Int J Biol Markers 2000; 15: 139-46.
15. Romain S, Martin PM, Klijn JG, et al. DNA-synthesis enzyme activity: A biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer? Int J Cancer 1997; 74: 156-61.
16. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-77.
17. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846-52.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
19. Romain S, Spyratos F, Guirou O, Deytieux S, Chinot O, Martin PM. Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report. Eur J Cancer 1994; 30A: 2163-5.
20. Bradshaw Jr., HD Deininger PL. Human thymidine kinase gene: Molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol Cell Biol 1984; 4: 2316-20.
21. Berenstein D, Christensen JF, Kristensen T, Hofbauer R, Munch-Petersen M. Valine, not methionine, is amino acid 106 in human cytosolic thymidine kinase. J Biol Chem 2000; 41: 32187-92.
22. Koonin EV, Senkevich TG. Evolution of thymidine and thymidylate kinases: The possibility of independent capture of TK genes by different groups of viruses. Virus Genes 1992; 6: 187-96.